Related Experiment Video
Updated: Jun 27, 2026

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
A global evaluation of voriconazole activity tested against recent clinical isolates of Candida spp
Daniel J Diekema1, Shawn A Messer, Richard J Hollis
1Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA. daniel-diekema@uiowa.edu
Abstract:
Voriconazole susceptibility testing was performed on 7191 Candida spp. from 78 centers worldwide between 2004 and 2007. Voriconazole was very active in vitro (MIC(50)/MIC(90), 0.008/0.25 microg/mL; 98% susceptible). In comparison to 5866 Candida spp. isolates collected during global surveillance from 1997 to 2001, there were no changes in voriconazole mean MIC or MIC distribution.
More Related Videos
Related Concept Videos
Antifungal Agents
Candidiasis
Antimicrobial Effectiveness
Cryptococcal Meningitis

